These results suggest that in addition to a remodeling of purinergic receptor-mediated Ca2+ signaling [19], EGF-induced EMT in MDA-MB-468 breast cancer cells is associated with a significant reduction in non-stimulated Ca2+ influx. Here, EGF is linked to breast cancer.